Showing results (571-580 of 595) with videos related to
Sort By:
Pageof 60
Gut|December 13, 2002
CARD4/NOD1 is not involved in inflammatory bowel diseaseH Zouali, S Lesage, F Merlin, et al.Journal of Computational Chemistry|April 27, 2013
PHAISTOS: a framework for Markov chain Monte Carlo simulation and inference of protein structureWouter Boomsma, Jes Frellsen, Tim Harder, et al.The Review of Scientific Instruments|April 9, 2020
A versatile Johansson-type tender x-ray emission spectrometerS H Nowak, R Armenta, C P Schwartz, et al.Alimentary Pharmacology & Therapeutics|March 15, 2018
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infectionJ von Felden, J Vermehren, P Ingiliz, et al.European Journal of Nuclear Medicine and Molecular Imaging|January 12, 2023
Application of 89Zr-DFO*-immuno-PET to assess improved target engagement of a bispecific anti-amyloid-ß monoclonal antibodyN Stergiou, T E Wuensche, M Schreurs, et al.Science Advances|July 10, 2026
Multifunctional electrochemical memory stabilized by phase coexistenceSangheon Oh, Adam L Gross, Adam S Christensen, et al.Abdominal Radiology (New York)|September 22, 2022
Inter- and intra-observer variability of computed tomography-based parenchymal- and ductal diameters in chronic pancreatitis: a multi-observer international studyJens Borgbjerg, Emily Steinkohl, Søren S Olesen, et al.Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.Journal of Viral Hepatitis|March 26, 2017
Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and dasabuvir for the treatment of chronic hepatitis C virus infection in the German Hepatitis C RegistryT M Welzel, H Hinrichsen, C Sarrazin, et al.JAMA Cardiology|November 12, 2025
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical TrialDeborah M Siegal, Christian Sticherling, Jeff S Healey, et al.Pageof 60